People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses

BACKGROUND: Longer-term humoral responses to 2-dose coronavirus disease 2019 (COVID-19) vaccines remain incompletely characterized in people living with human immunodeficiency virus (HIV) (PLWH), as do initial responses to a third dose. METHODS: We measured antibodies against the severe acute respir...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapointe, Hope R, Mwimanzi, Francis, Cheung, Peter K, Sang, Yurou, Yaseen, Fatima, Umviligihozo, Gisele, Kalikawe, Rebecca, Speckmaier, Sarah, Moran-Garcia, Nadia, Datwani, Sneha, Duncan, Maggie C, Agafitei, Olga, Ennis, Siobhan, Young, Landon, Ali, Hesham, Ganase, Bruce, Omondi, F Harrison, Dong, Winnie, Toy, Junine, Sereda, Paul, Burns, Laura, Costiniuk, Cecilia T, Cooper, Curtis, Anis, Aslam H, Leung, Victor, Holmes, Daniel T, DeMarco, Mari L, Simons, Janet, Hedgcock, Malcolm, Prystajecky, Natalie, Lowe, Christopher F, Pantophlet, Ralph, Romney, Marc G, Barrios, Rolando, Guillemi, Silvia, Brumme, Chanson J, Montaner, Julio S G, Hull, Mark, Harris, Marianne, Niikura, Masahiro, Brockman, Mark A, Brumme, Zabrina L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214159/
https://www.ncbi.nlm.nih.gov/pubmed/35668700
http://dx.doi.org/10.1093/infdis/jiac229

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9214159/
https://www.ncbi.nlm.nih.gov/pubmed/35668700
http://dx.doi.org/10.1093/infdis/jiac229

Ejemplares similares